Arezo Torang

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 12, 2025
GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells.

Le Zhang, Lidia Atencia Taboada, Selami Baglamis

|Apr 06, 2025
CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer.

Valérie M Wouters, Roxan F C P A Helderman, Kate Cameron

|Jan 02, 2025
Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability.

Arezo Torang, Aleksandar B Kirov, Veerle Lammers

|Dec 25, 2024
NanoCMSer: a consensus molecular subtype stratification tool for fresh-frozen and paraffin-embedded colorectal cancer samples.

Arezo Torang, Simone van de Weerd, Veerle Lammers

|Aug 08, 2024
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer.

Simone van de Weerd, Arezo Torang, Inge van den Berg

|Mar 17, 2022
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Ronja S Adam, Dennis Poel, Leandro Ferreira Moreno

Pageof 2

Frequent Collaborators

3 joint publications

Valérie M Wouters

3 joint publications

Jan Paul Medema

2 joint publications

Patricia M Gomez Barila

2 joint publications

Owen Sansom